We observed milder EGFR expression in both younger and older patients, while those aged 50–70 exhibited higher expression levels, which may indicate more aggressive tumor growth and a poorer prognosis in this age group, as reflected in the literature [3,18]. The gene discussed is EGFR; the disease is neoplasm.